RegeneRx's Chief Executive Interviewed by Wall Street Transcript For Annual Biotechnology Issue

BETHESDA, Md.—(BUSINESS WIRE)—March 2, 2006—RegeneRx Biopharmaceuticals (AMEX:RGN) reported today that J.J. Finkelstein, president and chief executive officer, was interviewed by The Wall Street Transcript for its annual biotechnology issue, which was published this week. The full text of the interview may be accessed by clicking on a link on RegeneRx’s home page at www.regenerx.com.

Source: RegeneRx